Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This study looked at blinatumomab for people who had fast growing lymphoma that had come back or stopped responding to treatment.
People could join the study between 2017 and 2018. The team published the results in 2020.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 23 January 2017
Recruitment end: 15 January 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Andrew McMillan
Amgen
Last reviewed: 09 Oct 2026
CRUK internal database number: 14674
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
